The Top 5 Biosimilar Articles for the Week of August 16

Here are the top 5 biosimilar articles for the week of August 16, 2021.

Hi, I’m Skylar Jeremias for The Center for Biosimilars®, your resource for clinical, regulatory, business, and policy news in the rapidly changing world of biosimilars.

Here are the top 5 biosimilar articles for the week of August 16, 2021.

Number 5: Passage of HR 3 is shaping up as a centerpiece of President Biden's effort to bring pharmaceutical prices under control. If drug companies won't negotiate prices, international reference pricing would kick in.

Number 4: The LAVENDER study demonstrated safety and tolerability of simultaneous intravenous (IV) administration of biosimilar trastuzumab (Kanjinti) and pertuzumab in cohorts of healthy volunteers.

Number 3: A retrospective study of rituximab biosimilars Truxima and Riximyo demonstrated comparable response and survival for patients with diffuse large B-cell lymphoma (DLBCL).

Number 2: When it comes to their willingness to use biosimilars, providers and managed care pharmacists prefer greater transparency on formulary placement and costs, according to a focus group study based on health care surveys.

Number 1: If biosimilars development and sales have lost some of their luster for Pfizer, it’s understandable, given the tremendous boost it received from its COVID-19 vaccine, and the company said its vaccine business is just getting started, with new contracts being signed around the globe.

To read all of these articles and more, visit centerforbiosimilars.com.

Related Videos
Here are the top 5 biosimilar articles for the week of May 22, 2023.
Fran Gregory, PharmD, vice president of emerging therapies at Cardinal Health
Here are the top 5 biosimilar articles for the week of May 15th, 2023.
Here are the top 5 biosimilar articles for the week of May 8, 2023.
andre harvin
Here are the top 5 biosimilar articles for the week of May 1, 2023.
Here are the top 5 biosimilar articles for the week of April 24, 2023.
Andre Harvin, PharmD
Here are the top 5 biosimilar articles for the week of April 17, 2023.
Here are the top 5 biosimilar articles for the week of April 10, 2023.
Related Content
© 2023 MJH Life Sciences

All rights reserved.